FG Will Provide Ex-Servicemen’s Welfare, Says SGF


 Image result for Secretary to the Government of the Federation (SGF), Boss Mustapha,




The Secretary to the Government of the Federation (SGF), Boss Mustapha, has assured Nigerians that the federal government will cater for the welfare of war veterans, who fought and sacrificed to ensure national peace and international stability.

Mustapha made the pledge at the launch of the Nigerian Legion 2020 Emblem Appeal Launch on Wednesday.

The team of the Nigerian Legion led by its National Chairman, Brig. Gen Jones Akpa (rtd), was on a visit to the SGF, where it presented the 2020 Armed Forces Remembrance Day Emblem to him.

He said Nigeria has a duty to continue to remember those who laid down their lives to ensure stability, unity and peace in the country.

Mustapha recalled that the country earned international adulation for sacrificing a number of its military personnel in many peace keeping missions globally.

Akpa pleaded with the SGF to see to the cause of veteran administrations, and to support the families of personnel who lost their lives in the First and Second World Wars and the Nigerian civil war.

”There are many other socio-economic issues that impact on veterans and their off-springs that we in the Legion are empowered and compelled to tackle, such as provision of jobs, health care, subsidised accommodation, land, sea and air transportation as well as agro-allied industries on the Legion owned farms,” Akpa said.

He lauded President Muhammadu Buhari administration for ensuring a regular 30-day cycle of payment of pension to veterans, thereby removing the major impediment to their welfare.

Akpa also urged the SGF to inform other Ministries, Agencies and Departments (MDAs) that the Legion will be visiting them in continuation of the Emblem Appeal Launch.

Comments

Popular posts from this blog

Population of Doctors in Nigeria Hits 74,543

Court Stops National Assembly From Taking Over Bauchi Assembly

Drug Insecurity: House Urges FG to Fund Indigenous Drug Research